Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Interest & Investment Income (2022 - 2025)

Incannex Healthcare's Interest & Investment Income history spans 3 years, with the latest figure at $2000.0 for Q2 2025.

  • On a quarterly basis, Interest & Investment Income fell 95.0% to $2000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $62000.0, a 69.9% decrease, with the full-year FY2025 number at $62000.0, down 69.9% from a year prior.
  • Interest & Investment Income hit $2000.0 in Q2 2025 for Incannex Healthcare, down from $4000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for IXHL hit a ceiling of $75000.0 in Q1 2024 and a floor of $2000.0 in Q2 2025.
  • Historically, Interest & Investment Income has averaged $33500.0 across 3 years, with a median of $28000.0 in 2024.
  • Biggest five-year swings in Interest & Investment Income: soared 40.0% in 2024 and later plummeted 95.0% in 2025.
  • Tracing IXHL's Interest & Investment Income over 3 years: stood at $20000.0 in 2023, then soared by 40.0% to $28000.0 in 2024, then tumbled by 92.86% to $2000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for IXHL at $2000.0 in Q2 2025, $4000.0 in Q1 2025, and $28000.0 in Q4 2024.